Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis

Published:2020-03 Issue:1 Volume:6 Page:15-19
ISSN:2405-5255
Container-title:Osteoporosis and Sarcopenia
language:en
Short-container-title:Osteoporosis and Sarcopenia

Author:

Okamoto Hiroaki^ORCID,Shibazaki Nayumi^ORCID,Yoshimura Takeshi^ORCID,Uzawa Toyonobu^ORCID,Sugimoto Toshitsugu^ORCID

Funder

Asahi Kasei Pharma Corporation

Publisher

Elsevier BV

Subject

General Medicine

Reference7 articles.

1. European Medicines Agency recommends limiting long-term use of calcitonin medicines,2012

2. A randomized, double-blind, placebo-controlled study of once weekly elcatonin in primary postmenopausal osteoporosis;Sugimoto;Curr Med Res Opin,2019

3. Salmon calcitonin use and associated cancer risk;Overman;Ann Pharmacother,2013

4. Calcitonin use and risk of malignancy: a meta-analysis of 17 RCTs in patients with osteoporosis [abstract 1234];Heep,2012

5. Does salmon calcitonin cause cancer? A review and meta-analysis;Wells;Osteoporos Int,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective;Annals of Hematology;2023-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP